| 21/667 |
Treatment of Dermatological and Rheumatological Conditions |
| 21/666 |
Low and Mid Tech Communication Aid Device |
| 21/664 |
Medication Treatments |
| 21/663 |
Agency Staff |
| 21/660 |
Clinic Letters |
| 21/659 |
Impact of Covid Visiting Policies |
| 21/658 |
Trust Nursing Staff |
| 21/657 |
Maternity Beds |
| 21/654 |
Treatment of Ovarian Cancer |
| 21/652 |
Treatment of Urothelial Cancer |
| 21/651 |
Data Management Systems |
| 21/650 |
Patient Safety Incidents Resulting in Severe Harm or Death |
| 21/649 |
COVID-19 |
| 21/648 |
Haemophilia A Patients |
| 21/645 |
Treatment of Dermatological Conditions |
| 21/644 |
Endoscopy Administrative Staff |
| 21/643 |
Mailing |
| 21/642 |
Maternity Services |
| 21/640 |
External Courier Use |
| 21/638 |
Hospital Staff Assaults |
